Duality Biotherapeutics Sets 24–29 April 2026 Book Closure for Extraordinary General Meeting

Bulletin Express04-09

Duality Biotherapeutics, Inc. will convene an Extraordinary General Meeting (EGM) at 9:00 a.m. on Wednesday, 29 April 2026, in the Board Room, 11/F, Building A, No. 868 Yinghua Road, Pudong New Area, Shanghai, PRC.

The company’s register of members will be closed from Friday, 24 April 2026 to Wednesday, 29 April 2026 (both days inclusive). During this period, no share transfers will be registered. Shareholders wishing to qualify for attendance and voting must lodge share transfer documents with Computershare Hong Kong Investor Services Limited (Shops 1712-1716, 17/F, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong) by 4:30 p.m. on Thursday, 23 April 2026.

A circular, notice of the EGM and related proxy form will be dispatched to shareholders in due course.

The Board currently comprises three executive directors (Dr. Zhu Zhongyuan, Mr. Zhang Shaoren, Dr. Hua Haiqing), two non-executive directors (Mr. Cai Zhiyang, Dr. Yu Tao) and three independent non-executive directors (Mr. Xie Dong, Mr. Gao Fengyong, Ms. Chuai Shuyin).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment